Literature DB >> 8243503

Metabolism of S-nicotine in noninduced and aroclor-induced rats.

G Schepers1, K Rustemeier, R A Walk, U Hackenberg.   

Abstract

The urinary excretion of nicotine and its metabolites in noninduced and Aroclor-induced male and female rats has been determined following intravenous administration of 2'-[14C]-labeled S-nicotine at a dose of 4.6 mumol/kg. Complete recovery of the administered radioactivity was achieved: 95% in urine and 4% in feces over 96 h and 1% remaining in the body. More than 40 nicotine metabolites were found by radio-HPLC; 19 were identified including the cis/trans-diastereomers of nicotine-N'-oxide and 3'-hydroxycotinine. The urinary metabolite profile and excretion kinetics of nicotine and its metabolites were significantly different between noninduced and Aroclor-induced rats. The major urinary nicotine metabolite in the noninduced rat was cis-nicotine-N'-oxide. In the Aroclor-induced rat, cotinine metabolites were the major metabolites found. Sex differences were found for the urinary nicotine metabolite profile, mainly expressed in the excretion of cis-nicotine-N'-oxide, 29% in the male and 17% in the female noninduced rat, and the excretion of cotinine, 5% in the male and 12% in the female noninduced rat. High stereoselectivity was found for the formation of the cis/trans-diastereomers of nicotine-N'-oxide as well as of 3'-hydroxycotinine, the stereoselectivity being more pronounced in male rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243503     DOI: 10.1007/BF03188795

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  35 in total

1.  Identification of cis-3'-hydroxycotinine as a urinary nicotine metabolite.

Authors:  P Voncken; K Rustemeier; G Schepers
Journal:  Xenobiotica       Date:  1990-12       Impact factor: 1.908

2.  Comparative C- and N-oxidation of (plus)- and (minus)-nicotine by various species.

Authors:  P Jenner; J W Gorrod; A H Beckett
Journal:  Xenobiotica       Date:  1971 Jul-Oct       Impact factor: 1.908

3.  The metabolism of nicotine into two optically-active stereoisomers of nicotine-1'-oxide by animal tissues in vitro and by cigarette smokers.

Authors:  J Booth; E Boyland
Journal:  Biochem Pharmacol       Date:  1970-03       Impact factor: 5.858

4.  High-performance liquid chromatographic determination of nicotine and its urinary metabolites via their 1,3-diethyl-2-thiobarbituric acid derivatives.

Authors:  K Rustemeier; D Demetriou; G Schepers; P Voncken
Journal:  J Chromatogr       Date:  1993-03-05

5.  High-performance liquid chromatographic method for the determination of N-methylated metabolites of nicotine.

Authors:  K C Cundy; P A Crooks
Journal:  J Chromatogr       Date:  1984-03-09

6.  Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavone-treated rats.

Authors:  H Foth; H Looschen; H Neurath; G F Kahl
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

7.  Metabolic oxidation of nicotine to chemically reactive intermediates.

Authors:  T L Nguyen; L D Gruenke; N Castagnoli
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

8.  Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity.

Authors:  A Lemoine; D E Williams; T Cresteil; J P Leroux
Journal:  Mol Pharmacol       Date:  1991-08       Impact factor: 4.436

9.  Remarkable substrate-inhibitor properties of nicotine enantiomers towards a guinea pig lung aromatic azaheterocycle N-methyltransferase.

Authors:  K C Cundy; P A Crooks; C S Godin
Journal:  Biochem Biophys Res Commun       Date:  1985-04-16       Impact factor: 3.575

10.  The effects of some tobacco smoke constituents on foreign compound metabolism in the cat and the rat.

Authors:  D M Turner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-03
View more
  5 in total

1.  Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Sheri Booth; Maysa A Gharib; Laure A Craven; Shannon S Allen; Alan F Sved; Kenneth A Perkins
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

Review 2.  Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se.

Authors:  Hans-Juergen Haussmann; Marc W Fariss
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

3.  Pharmacokinetics and metabolism of N-(2-hydroxyethyl)-2,5-[14C]-pyrrolidine (HEP, Epolamine) in male healthy volunteers.

Authors:  C Giachetti; A Assandri; G Mautone; E Tajana; B Palumbo; R Palumbo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

Review 4.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

5.  Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: subchronic inhalation toxicology.

Authors:  O Moennikes; P M Vanscheeuwijck; B Friedrichs; E Anskeit; G J Patskan
Journal:  Inhal Toxicol       Date:  2008-05       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.